CSF sTREM2 is elevated in a subset in GRN-related frontotemporal dementia
Open Access
- 1 July 2021
- journal article
- research article
- Published by Elsevier in Neurobiology of Aging
- Vol. 103, 158.e1-158.e5
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- Alzheimer Nederland
- Swedish Research Council
- Netherlands Organisation for Health Research and Development
This publication has 31 references indexed in Scilit:
- sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markersEMBO Molecular Medicine, 2016
- Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s diseaseMolecular Neurodegeneration, 2016
- Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation statusActa Neuropathologica, 2016
- TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosisScience Translational Medicine, 2014
- Innate immune activation in neurodegenerative diseaseNature Reviews Immunology, 2014
- Exacerbated inflammatory responses related to activated microglia after traumatic brain injury in progranulin-deficient miceNeuroscience, 2013
- Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injuryJournal of Clinical Investigation, 2012
- Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementiaBrain, 2011
- Classification of primary progressive aphasia and its variantsNeurology, 2011
- Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammationBrain, 2008